SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-21-001671
Filing Date
2021-07-26
Accepted
2021-07-26 12:40:36
Documents
2
Period of Report
2021-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K skye_8k.htm 8-K 17618
2 PRESS RELEASE skye_ex991.htm EX-99.1 9563
  Complete submission text file 0001640334-21-001671.txt   28739
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 211113415
SIC: 2834 Pharmaceutical Preparations